Participation in CHINA BIO, BIO PHAMA AMERICA and BIO EUROPE

Neu REFIX beta glucans improving Multiple Sclerosis patients’ gut microbiome awarded as the best poster

Nichi BRITE Beta glucans yileding clinically encouraging outcome in a trial was presented in the webinar that commemorated World Parkinsons Day held on the 10th April 2023

Neurology Live, a clinical neurologists focused media portal has published GN Corporation’s presentation at the MDA on the Clinical trial results of Neu REFIX in Duchenne Muscular Dystrophy

GN Corporation will present the results of preclinical and clinical studies with neu REFIX (N-163), one of its